OBIO
Orchestra BioMed Holdings Inc.
6.00$
+3.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2,453.9% | -4,188.5% | -2,115.2% | -1,311.8% | -1,388.0% | -5,351.0% | -1,914.3% | -1,857.3% | -1,689.9% | -7.3% | -20,152.7% | -21,968.2% | -182.4% | |
| 16.9% | 27.5% | 11.9% | 9.5% | 7.7% | 33.2% | 9.6% | 9.7% | 9.4% | 0.3% | 81.8% | 109.1% | 1.1% | |
| 837.7% | 350.8% | 417.4% | 354.9% | 239.5% | 1,147.0% | 341.6% | 388.8% | 349.9% | 8.9% | 2,591.8% | 2,846.6% | 34.8% | |
| 146.3% | -44.3% | -295.8% | 394.7% | -125.3% | -538.7% | -114.1% | 42.8% | 295.1% | -39.7% | -3,330.0% | 126.1% | -41.6% | |
| 4.5% | 1.1% | 1.3% | 13.8% | 6.9% | 41.9% | 12.9% | 4.1% | 36.0% | 0.1% | 167.3% | 288.6% | 2.4% | |
| 3,090.0% | 12,653.1% | 945.3% | 1,339.8% | 56.4% | -1,483.4% | 1,497.6% | 1,956.5% | -4,481.3% | -57.3% | 9,380.0% | -26,487.5% | -216.7% | |
| – | – | – | – | – | – | – | -51.2% | – | – | – | -700.0% | – | |
| 1.0% | -4,082.4% | 2.9% | 22.0% | 1,523.3% | 5,512.6% | -34.1% | -51.2% | 8,873.1% | 40.9% | 5,024.5% | 39,484.1% | 404.5% | |
| 637.0% | 4,382.1% | -1,166.9% | 50.0% | 191.7% | -1,321.7% | -450.8% | 48.0% | 2,701.9% | -23.7% | -5,748.2% | -8,971.6% | 5.4% | |
| -2,458.5% | -4,187.4% | -2,116.5% | -1,325.6% | -1,394.9% | -5,392.9% | -1,927.2% | -1,861.4% | -1,725.9% | -7.4% | -20,320.0% | -22,256.8% | -184.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.